Onconetix, Inc. Accrued Liabilities, Current
Onconetix, Inc. (ONCO) had Accrued Liabilities, Current of $249.61 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $249.61K.
- 2026-03-31: Accrued Liabilities, Current $279.12K.
- 2025-12-31: Accrued Liabilities, Current $341.88K.
- 2025-09-30: Accrued Liabilities, Current $476.29K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $249.61K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $279.12K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $341.88K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $476.29K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $894.99K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.16M 10-Q · filed 2025-06-12 |
| 2024-12-31 | $888.99K 10-K · filed 2026-03-13 |
| 2024-09-30 | $1.34M 10-Q · filed 2024-12-10 |
| 2024-06-30 | $1.44M 10-Q · filed 2024-08-29 |
| 2024-03-31 | $1.94M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $2.20M 10-K · filed 2025-06-02 |
| 2023-09-30 | $1.54M 10-Q · filed 2023-11-17 |
| 2023-06-30 | $1.42M 10-Q · filed 2023-10-20 |
| 2023-03-31 | $1.29M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.41M 10-K · filed 2024-04-11 |
| 2022-09-30 | $3.56M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.08M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.89M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.06M 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |